US Stock MarketDetailed Quotes

BLPH Bellerophon Therapeutics

Watchlist
  • 0.055
  • 0.0000.00%
15min DelayClose Nov 21 16:00 ET
672.80KMarket Cap-61P/E (TTM)

Bellerophon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
5.64M
0
0
0
0
0
0
0
Operating revenue
--0
--0
--5.64M
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-57.58%2.17M
-19.60%5.26M
-26.25%4.16M
11.03%22.38M
19.00%5.09M
6.52%5.12M
25.16%6.54M
-3.70%5.64M
-23.27%20.16M
-47.54%4.27M
Selling and administrative expenses
19.03%1.63M
15.15%2.36M
30.49%1.61M
-15.73%6.02M
23.22%1.37M
-22.96%1.37M
3.32%2.05M
-45.80%1.23M
-14.79%7.15M
-44.73%1.11M
-General and administrative expense
19.03%1.63M
15.15%2.36M
30.49%1.61M
-15.73%6.02M
23.22%1.37M
-22.96%1.37M
3.32%2.05M
-45.80%1.23M
-14.79%7.15M
-44.73%1.11M
Research and development costs
-85.49%544K
-35.49%2.9M
-42.12%2.55M
25.72%16.36M
17.52%3.72M
23.76%3.75M
38.56%4.49M
23.02%4.41M
-27.25%13.02M
-48.47%3.16M
Operating profit
57.58%-2.17M
19.60%-5.26M
126.21%1.48M
-11.03%-22.38M
-19.00%-5.09M
-6.52%-5.12M
-25.16%-6.54M
3.70%-5.64M
23.27%-20.16M
47.54%-4.27M
Net non-operating interest income expense
131.91%109K
536.84%121K
6,500.00%66K
2,600.00%135K
6,700.00%68K
2,250.00%47K
1,800.00%19K
0.00%1K
102.00%5K
100.33%1K
Non-operating interest income
131.91%109K
536.84%121K
6,500.00%66K
----
----
2,250.00%47K
1,800.00%19K
0.00%1K
----
----
Total other finance cost
----
----
----
-2,600.00%-135K
----
----
----
----
-102.00%-5K
----
Other net income (expense)
140K
-99.83%1K
283.49%600K
0
Gain on sale of security
----
----
----
-99.83%1K
----
----
----
----
283.49%600K
--0
Special income (charges)
--140K
----
----
----
----
--0
----
----
----
----
-Gain on sale of property,plant,equipment
--140K
----
----
----
----
--0
----
----
----
----
Income before tax
62.10%-1.92M
21.22%-5.14M
127.39%1.55M
-13.77%-22.25M
-17.42%-5.02M
-9.39%-5.07M
-25.69%-6.52M
-3.30%-5.64M
27.17%-19.56M
46.63%-4.27M
Income tax
0
0
-1.28M
-34.28%-2.42M
0
0
-34.28%-2.42M
0
15.29%-1.8M
0
Net income
62.10%-1.92M
-25.16%-5.14M
150.03%2.82M
-11.69%-19.83M
-17.42%-5.02M
-9.39%-5.07M
-21.13%-4.11M
-3.30%-5.64M
28.19%-17.76M
46.63%-4.27M
Net income continuous Operations
62.10%-1.92M
-25.16%-5.14M
150.03%2.82M
-11.69%-19.83M
-17.42%-5.02M
-9.39%-5.07M
-21.13%-4.11M
-3.30%-5.64M
28.19%-17.76M
46.63%-4.27M
Minority interest income
Net income attributable to the parent company
62.10%-1.92M
-25.16%-5.14M
150.03%2.82M
-11.69%-19.83M
-17.42%-5.02M
-9.39%-5.07M
-21.13%-4.11M
-3.30%-5.64M
28.19%-17.76M
46.63%-4.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
62.10%-1.92M
-25.16%-5.14M
150.03%2.82M
-11.69%-19.83M
-17.42%-5.02M
-9.39%-5.07M
-21.13%-4.11M
-3.30%-5.64M
28.19%-17.76M
46.63%-4.27M
Basic earnings per share
69.81%-0.16
2.33%-0.42
145.76%0.27
-11.23%-2.08
-17.78%-0.53
-8.16%-0.53
-19.44%-0.43
-1.72%-0.59
41.01%-1.87
47.67%-0.45
Diluted earnings per share
69.81%-0.16
2.33%-0.42
145.76%0.27
-11.23%-2.08
-17.78%-0.53
-8.16%-0.53
-19.44%-0.43
-1.72%-0.59
41.01%-1.87
47.67%-0.45
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 005.64M0000000
Operating revenue --0--0--5.64M--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -57.58%2.17M-19.60%5.26M-26.25%4.16M11.03%22.38M19.00%5.09M6.52%5.12M25.16%6.54M-3.70%5.64M-23.27%20.16M-47.54%4.27M
Selling and administrative expenses 19.03%1.63M15.15%2.36M30.49%1.61M-15.73%6.02M23.22%1.37M-22.96%1.37M3.32%2.05M-45.80%1.23M-14.79%7.15M-44.73%1.11M
-General and administrative expense 19.03%1.63M15.15%2.36M30.49%1.61M-15.73%6.02M23.22%1.37M-22.96%1.37M3.32%2.05M-45.80%1.23M-14.79%7.15M-44.73%1.11M
Research and development costs -85.49%544K-35.49%2.9M-42.12%2.55M25.72%16.36M17.52%3.72M23.76%3.75M38.56%4.49M23.02%4.41M-27.25%13.02M-48.47%3.16M
Operating profit 57.58%-2.17M19.60%-5.26M126.21%1.48M-11.03%-22.38M-19.00%-5.09M-6.52%-5.12M-25.16%-6.54M3.70%-5.64M23.27%-20.16M47.54%-4.27M
Net non-operating interest income expense 131.91%109K536.84%121K6,500.00%66K2,600.00%135K6,700.00%68K2,250.00%47K1,800.00%19K0.00%1K102.00%5K100.33%1K
Non-operating interest income 131.91%109K536.84%121K6,500.00%66K--------2,250.00%47K1,800.00%19K0.00%1K--------
Total other finance cost -------------2,600.00%-135K-----------------102.00%-5K----
Other net income (expense) 140K-99.83%1K283.49%600K0
Gain on sale of security -------------99.83%1K----------------283.49%600K--0
Special income (charges) --140K------------------0----------------
-Gain on sale of property,plant,equipment --140K------------------0----------------
Income before tax 62.10%-1.92M21.22%-5.14M127.39%1.55M-13.77%-22.25M-17.42%-5.02M-9.39%-5.07M-25.69%-6.52M-3.30%-5.64M27.17%-19.56M46.63%-4.27M
Income tax 00-1.28M-34.28%-2.42M00-34.28%-2.42M015.29%-1.8M0
Net income 62.10%-1.92M-25.16%-5.14M150.03%2.82M-11.69%-19.83M-17.42%-5.02M-9.39%-5.07M-21.13%-4.11M-3.30%-5.64M28.19%-17.76M46.63%-4.27M
Net income continuous Operations 62.10%-1.92M-25.16%-5.14M150.03%2.82M-11.69%-19.83M-17.42%-5.02M-9.39%-5.07M-21.13%-4.11M-3.30%-5.64M28.19%-17.76M46.63%-4.27M
Minority interest income
Net income attributable to the parent company 62.10%-1.92M-25.16%-5.14M150.03%2.82M-11.69%-19.83M-17.42%-5.02M-9.39%-5.07M-21.13%-4.11M-3.30%-5.64M28.19%-17.76M46.63%-4.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 62.10%-1.92M-25.16%-5.14M150.03%2.82M-11.69%-19.83M-17.42%-5.02M-9.39%-5.07M-21.13%-4.11M-3.30%-5.64M28.19%-17.76M46.63%-4.27M
Basic earnings per share 69.81%-0.162.33%-0.42145.76%0.27-11.23%-2.08-17.78%-0.53-8.16%-0.53-19.44%-0.43-1.72%-0.5941.01%-1.8747.67%-0.45
Diluted earnings per share 69.81%-0.162.33%-0.42145.76%0.27-11.23%-2.08-17.78%-0.53-8.16%-0.53-19.44%-0.43-1.72%-0.5941.01%-1.8747.67%-0.45
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data